EMEA-000329-PIP02-09-M05
Key facts
| Invented name |
Aranesp
|
| Active substance |
darbepoetin alfa
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0147/2016
|
| PIP number |
EMEA-000329-PIP02-09-M05
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of anaemia due to chronic disorders
|
| Route(s) of administration |
|
| Contact for public enquiries |
Amgen Europe B.V
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-000329-PIP02-09-M05
|
| Compliance opinion date |
24/03/2017
|
| Compliance outcome |
negative
|